Recurrence: all 3,523 studies

Page 32 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.

• Prevention Relapse of Graves' Disease by Intrathyroid Injection of DexamethasoneCompletedNCT00917241Phase 4
• Trial Between Two Follow up Regimens With Different Test Intensity in Endometrial Cancer Treated PatientsStatus unknownNCT00916708Not applicable
• Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed)CompletedNCT00916630Phase 1
• Managing Non-acute Low Back Symptoms in Occupational Health: Two TrialsStatus unknownNCT00908102Not applicable
• ASCT for Relapsed APL After Molecular RemissionTerminatedNCT00907582Phase 2
• Study of ENMD-2076 in Patients With Relapsed or Refractory Hematological MalignanciesCompletedNCT00904787Phase 1
• Collecting and Storing Blood Samples From Patients With CancerWithdrawnNCT00900120
• Assessing Arsenic Trioxide in Young Patients With Leukemia or Lymphoma Who Were Treated on Clinical Trial NCI-00-C-0070JCompletedNCT00899015
• Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow TransplantWithdrawnNCT00898612
• Efficacy and Safety of Intramuscular HBIG Grifols for the Prevention of Recurrence After Liver TransplantationCompletedNCT00895713Phase 2
• Phase 2 Study MPC-6827 for Recurrent Glioblastoma MultiformeCompletedNCT00892931Phase 2
• Long-term Follow-up of Incisional Hernia Repaired With Intraperitoneal MeshCompletedNCT00891254Phase 1
• Efficacy of Topotecan and Lapatinib in Early Recurrent Ovarian or Peritoneal CancerTerminatedNCT00888810Phase 2
• Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and NeutropeniaWithdrawnNCT00886496Phase 1
• A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary GlandsCompletedNCT00886132Phase 2
• Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/RelapsersTerminatedNCT00882193Early Phase 1
• Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.WithdrawnNCT00874315Phase 2
• A Study of CP-751,871 in Patients With Recurrent Squamous Head and Neck CarcinomaTerminatedNCT00872404Phase 2
• Masitinib in Relapse or Refractory Multiple Myeloma With t(4/14) Translocation Expressing or Not FGFR3CompletedNCT00866138Phase 2
• Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad PrognosisCompletedNCT00864318Phase 2
• Extended Treatment With Vancomycin for Clostridium Difficile ColitisWithdrawnNCT00861887Not applicable
• Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute LeukemiasTerminatedNCT00852709Phase 1
• Risperidone Maintenance Treatment in SchizophreniaCompletedNCT00848432Phase 4
• Efficacy and Safety of the Farnesyl-transferase Inhibitor (Tipifarnib) in Mantle Cell LymphomaTerminatedNCT00847223Phase 2
• Pharmacokinetic Study of Avastin and Doxil in Ovarian CancerCompletedNCT00846612Phase 1
• Evaluation of Serum Levels and Pharmacokinetics of a New Hepatitis B Immune Globulin Following Liver TransplantationCompletedNCT00838071Phase 3
• Prospective Randomized Trial Comparing THD Versus Stapler Operation for 3rd Degree HemorrhoidsStatus unknownNCT00823784Phase 3
• Oral Forodesine Hydrochloride (BCX-1777) in Patients With Recurrent or Refractory T/NK-cell MalignanciesCompletedNCT00823355Phase 1
• PET/CT Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast CancerTerminatedNCT00816582Not applicable
• Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral ResectionStatus unknownNCT00816075Phase 2/3
• CYP2D6 Genotyping by AmpliChipTM CYP450 for Tamoxifen-Treated Breast Cancer PatientsStatus unknownNCT00815555
• Pilot Human Study of Tinidazole Efficacy For Radical Cure Of Plasmodium VivaxCompletedNCT00811096Phase 2
• Study of Efficacy and Safety of Valproic Acid in Chronic Lymphocytic Leukemia (CLL)Status unknownNCT00810680Not applicable
• Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC)TerminatedNCT00805012Phase 2
• Denileukine Diftitox for Relapsed ALCLWithdrawnNCT00801918Phase 2
• Stapler Versus Glue for Laparoscopic Groin Hernia RepairCompletedNCT00793286Not applicable
• Pilot Study of IV and IP Chemotherapy Plus Abdominal Hyperthermia for Ovarian CaWithdrawnNCT00787488Not applicable
• Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid CancerStatus unknownNCT00786552Phase 2
• Allo-hNHL (FluBuCy)CompletedNCT00785330Phase 2
• An Educational and Exercise Program as Secondary Prevention of Recurrent Lower Back Pain in Healthcare WorkersCompletedNCT00782925Not applicable
• A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their FamiliesCompletedNCT00782145Phase 3
• Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance PatientsCompletedNCT00780702Phase 1
• Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AMLCompletedNCT00780598Phase 2
• GCS-100LE in Combination With Etoposide and Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell LymphomaWithdrawnNCT00776802Phase 1/2
• Transfacial Sutures Versus Stapler for Mesh Fixation in Laparoscopic Ventral Hernia RepairCompletedNCT00773851Not applicable
• A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)Status unknownNCT00772317Not applicable
• Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus InfectionsStatus unknownNCT00769613Phase 1
• Study of Cytokine-induced Killer Cell (CIK) Treatment in Patients After Resection of Liver CancerCompletedNCT00769106Phase 3
• Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular CarcinomaStatus unknownNCT00768157Phase 4
• High Dose, Absorbed Dose Adjusted 90Y-ibritumomab With Peripheral Blood Stem Cells (PBSC) Support in B-cell LymphomaCompletedNCT00761384Phase 1/2
• Differentiating Recurrent Brain Tumor Versus Radiation Injury Using MRICompletedNCT00760409
• A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid TumorsCompletedNCT00756340Phase 1
• Oral Corticotherapy in Megadoses to Treat Multiple Sclerosis During RelapseCompletedNCT00753792Phase 4
• A Japan Phase I/II Study of Bortezomib in Relapsed or Refractory Multiple Myeloma PatientsCompletedNCT00752518Phase 1/2
• A Study of Oral Clofarabine in Adult Patients With Myelodysplastic Syndromes (MDS)TerminatedNCT00750334Phase 1
• Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical TrialCompletedNCT00750009Phase 3
• Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in ChildrenCompletedNCT00749723Phase 2/3
• Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)CompletedNCT00747799Phase 2
• Once Daily (OD) Versus Three Times Daily (TID) Dosing With Mesalazine Granules for Prevention of Recurrence of Ulcerative Colitis (UC)CompletedNCT00746447Phase 3
• Impulsivity, Neural Deficits and Cocaine AddictionCompletedNCT00744601
• Stress, Hypothalamic-pituitary-adrenal (HPA) Dysfunction, and Relapse in AlcoholismCompletedNCT00744588
• Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma.TerminatedNCT00742495Phase 1/2
• A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced MalignanciesCompletedNCT00741403Phase 1
• Study of Individualized Wound Prevention Instruction to Prevent Venous Ulcer DevelopmentTerminatedNCT00727701Phase 1
• Trastuzumab for HER2 Positive Relapsed/Refractory B-Acute Lymphoblastic Leukemia (B-ALL)TerminatedNCT00724360Phase 2
• Safety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT00723359Phase 1
• Administration of Allogenic Red Blood Cells Loaded L-asparaginase in Cases of Relapse of Acute Lymphoblastic LeukaemiaCompletedNCT00723346Phase 1/2
• Upper Vaginectomy Versus Brachytherapy in Patients With Early Stage Endometrial Cancer Treated With Laparoscopic SurgeryStatus unknownNCT00719017Phase 4
• Safety and Dose Study of GRN163L and Velcade to Treat Patients With Refractory or Relapsed MyelomaCompletedNCT00718601Phase 1
• Study With Information Technology (IT) - Aided Preventive Program in SchizophreniaCompletedNCT00712660Not applicable
• Study of Pemetrexed to Treat Recurrent or Progressive Primary Central Nervous System LymphomaWithdrawnNCT00712062Phase 2
• Growth Relapse and Outcomes With Therapy 1CompletedNCT00711945
• Follow-up of Children After Stuttering TreatmentStatus unknownNCT00709072Phase 2
• T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLLCompletedNCT00709033Phase 1
• A Phase I-Ib/II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 Alone and in Combination With Bortezomib, With or Without Dexamethasone, in Patients With Relapsed or Refractory Multiple Myeloma.CompletedNCT00708292Phase 1/2
• A Study of Bortezomib and Pegylated Liposomal Doxorubicin in Patients With Relapsed Multiple Myeloma Previously Treated With BortezomibWithdrawnNCT00706953Phase 2
• Administration of Epstein Barr Virus - Specific Cytotoxic T-Lymphocytes to Metastatic EBV-Positive Nasopharygneal CancerCompletedNCT00706316Phase 1
• A Phase 1 Safety Study of LY2127399 in Combination With BortezomibCompletedNCT00689507Phase 1
• Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility StudyCompletedNCT00686465Not applicable
• Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic LeukemiaStatus unknownNCT00675870Phase 2
• A Phase I Study of BIIB015 in Relapsed/Refractory Solid TumorsCompletedNCT00674947Phase 1
• Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory LymphomaTerminatedNCT00671112Phase 1
• ChemoFx® PRO - A Post-Market Data Collection StudyTerminatedNCT00669422
• Efficacy Study of CYT997 in Multiple MyelomaTerminatedNCT00664378Phase 2
• Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid LeukemiaTerminatedNCT00660036Phase 1
• Randomized Study of Gonadotropin-releasing-hormone Agonist (GnRH-a) or Expectant Management for EndometriosisStatus unknownNCT00654524Phase 4
• Bortezomib/Adriamycine/Melfalan/Prednisone (VAMP)/Thalidomide/Cyclophosphamide/Dexamethasone (TaCyDex) or Bortezomib/Melfalan/Prednisone (V-MP)/TaCyDex) in Refractary or Relapsed Multiple MyelomaCompletedNCT00652041Phase 4
• Velcaflagida in Relapsed or Refractary Acute Myeloid LeukemiaCompletedNCT00651781Phase 1/2
• Phase ⅡStudy of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) PatientsStatus unknownNCT00644020
• Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and RibavirinTerminatedNCT00641654Phase 4
• Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated LymphomaCompletedNCT00641381Phase 1
• Recurrence Rate and Esthetic Outcome After Excision of Basal Cell Carcinomas Excluded From Trial NCT00515970Status unknownNCT00639652
• Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma MultiformeStatus unknownNCT00635557Phase 1/2
• Assessment and Determination of Chemotherapy Resistance in Newly-Diagnosed or First Relapse Leukemia PatientsTerminatedNCT00631059Not applicable
• Impact of PET Scan on the Curative Strategy of Colo-rectal Cancers : A Randomized StudyCompletedNCT00624260Not applicable
• Early Infectious Disease Consultations in Staphylococcus Aureus BacteremiaStatus unknownNCT00622882Not applicable
• Prospective Randomized Trial Comparing the New Endovenous Procedures Versus Conventional Surgery for Varicose Veins Due to Great Saphenous Vein IncompetenceCompletedNCT00621062Not applicable
• 12-week Safety Evaluation of Oral CS-0777 in Multiple Sclerosis PatientsCompletedNCT00616733Phase 1
• Allogenic Stem Cell Transplantation for Children, Adolescents and Young Adults With Relapsed or Refractory AMLCompletedNCT00606723Phase 3
• Prospective Randomized Trial of Laparoscopic Versus Open Liver Resection for HCCStatus unknownNCT00606385Not applicable

← Recurrence overview